Search Prime Grants

R33CA281918

Project Grant

Overview

Grant Description
A platform to identify in vivo targets of covalent cancer drugs in 3D tissues.
Funding Goals
NOT APPLICABLE
Place of Performance
La Jolla, California 920371000 United States
Geographic Scope
Single Zip Code
Analysis Notes
Amendment Since initial award the total obligations have increased 97% from $450,690 to $885,944.
Scripps Research Institute was awarded Project Grant R33CA281918 worth $885,944 from National Cancer Institute in September 2023 with work to be completed primarily in La Jolla California United States. The grant has a duration of 3 years and was awarded through assistance program 93.394 Cancer Detection and Diagnosis Research. The Project Grant was awarded through grant opportunity Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed).

Status
(Ongoing)

Last Modified 8/20/24

Period of Performance
9/19/23
Start Date
8/31/26
End Date
55.0% Complete

Funding Split
$885.9K
Federal Obligation
$0.0
Non-Federal Obligation
$885.9K
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to R33CA281918

Transaction History

Modifications to R33CA281918

Additional Detail

Award ID FAIN
R33CA281918
SAI Number
R33CA281918-3496064775
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
PHZJFZ32NKH4
Awardee CAGE
08PA3
Performance District
CA-50
Senators
Dianne Feinstein
Alejandro Padilla

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $450,690 100%
Modified: 8/20/24